Xolair 150 MG/ML syringeml

Ended Awarded

Contract number
SPE2DB24FY20X
Awardee
Awarding agency
Obligated
$6,190

Award facts

Contract value 100% obligated
$6,189.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The delivery order is for the pharmaceutical product XOLAIR 150 MG/ML SYRINGE and has a firm fixed price of $6,189.60. The period of performance runs through February 13, 2024. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of pharmaceutical and medical supplies to military treatment facilities worldwide. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract SPE2DB24FY20X?

SPE2DB24FY20X was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 23, 2024.

How much is contract SPE2DB24FY20X worth?

The government has obligated $6,190 on SPE2DB24FY20X.

Is contract SPE2DB24FY20X an order under another contract?

Yes. SPE2DB24FY20X is a delivery order under SPE2DB22D9362, an indefinite delivery contract.

Was contract SPE2DB24FY20X competed?

The extent of competition for SPE2DB24FY20X was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award